Which drugmaker announced it would cut 9,000 jobs to reduce costs?

The correct choice is Novo Nordisk because they publicly stated their intention to reduce their workforce by 9,000 positions as part of a broader cost-cutting strategy. This decision reflects the company's efforts to streamline operations and respond to a changing economic landscape, which can include factors like pricing pressures, increased competition, and market demands. The announcement garnered significant attention due to its implications for both employees and the company's future financial health.

In contrast, while other drugmakers like Pfizer, Roche, and Merck may also engage in workforce adjustments or cost-saving measures, specific announcements or news regarding such reductions have not been as prominent or public as the one made by Novo Nordisk within the relevant timeframe. Understanding these dynamics provides valuable insight into how pharmaceutical companies manage operational challenges and adapt to evolving industry conditions.